Sveriges mest populära poddar

Bloomberg Intelligence

Bloomberg Intelligence

Bloomberg's Krutoholow on Mylan To Sell Generic EpiPen (Audio)

6 min•29 augusti 2016

Om avsnittet

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.

See omnystudio.com/listener for privacy information.

Fler avsnitt

Micron Gives Bullish Forecast, Even as Pay Raises Crimp Margins

Apple Is Ready to Make Long-Awaited Push Into Smart-Home Market

Smart Ring Maker Oura Delays IPO

Nvidia Boosts Share Buyback Program by $150 Billion

What The Bond Selloff Means For Your Wallet & Simplifying Finance For Your Family

Muse Powers Meta to Cusp of $2 Trillion in Best Month Since 2013

Meta Introduces Palm-Sized Device to Use Muse AI

Disney+ Price to Jump 13% to $21.49 Per Month

Meta’s New Muse AI App Makes Shopping Easier

Paramount to Settle Lawsuits Against WBD Deal

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.